×
Request Free Sample ×
ReportInfographic

Kindly complete the form below to receive a free sample of this Report

* Please use a valid business email

Leading companies partner with us for data-driven Insights

clients tt-cursor
Hero Background

US Global Pediatric Neurology Devices Market

ID: MRFR/MED/17952-HCR
100 Pages
Rahul Gotadki
October 2025

US Pediatric Neurology Devices Market Research Report By Product Type (neurostimulation, interventional neurology, csf management, neurosurgery devices) and By End User (hospitals & clinics, specialty center) - Growth & Industry Forecast 2025 To 2035

Share:
Download PDF ×

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

US Global Pediatric Neurology Devices Market Infographic
Purchase Options
Compare License
Summary Table of Contents Segmentation Download PDF

US Global Pediatric Neurology Devices Market Summary

The US Pediatric Neurology Devices market is projected to grow from 4 USD billion in 2024 to 9 USD billion by 2035, reflecting a robust CAGR of 7.65%.

Key Market Trends & Highlights

US Pediatric Neurology Devices Key Trends and Highlights

  • The market is expected to expand significantly, reaching 9 USD billion by 2035 from a base of 4 USD billion in 2024.
  • A compound annual growth rate of 7.65% is anticipated for the period from 2025 to 2035.
  • The increasing prevalence of neurological disorders among children is likely to drive market growth.
  • Growing adoption of advanced diagnostic technologies due to rising awareness of pediatric neurological conditions is a major market driver.

Market Size & Forecast

2024 Market Size 4 (USD Billion)
2035 Market Size 9 (USD Billion)
CAGR (2025-2035) 7.65%

Major Players

Integra LifeSciences, TheraNest, Zyga Technology, Medtronic, Boston Scientific, Abbott Laboratories, Stryker, Johnson and Johnson, Cochlear, NeuroSigma, Biogen, Blackrock Neurotech, NeuroPace, Neurovascular, Nervilab

Market Segment Insights

US Pediatric Neurology Devices Market Segment Insights

Neurology Devices Market Product Type Insights

The US Pediatric Neurology Devices Market has witnessed an expanding landscape, particularly within the Product Type segment, which reflects a diverse range of applications and innovations critical for the healthcare of the population. Neurostimulation devices play a pivotal role in managing chronic pain, neurological disorders, and mood disorders, and are increasingly embraced for their ability to enhance patient quality of life through minimally invasive techniques. As the aging population in the US continues to grow, the demand for such devices is set to rise, highlighting the significant opportunity for advancement in neurostimulation technologies to improve therapeutic outcomes.

Interventional neurology is another noteworthy area within the US Pediatric Neurology Devices Market, characterized by its focus on minimally invasive surgical procedures aimed at the treatment of various neurological conditions such as stroke and vascular disorders. This segment benefits from technological advancements, including improved imaging techniques and robotic assistance, allowing for increased precision and improved patient recovery times. The growing prevalence of vascular diseases in the US population further highlights the importance of interventional neurology in addressing critical health challenges.

Cerebrospinal fluid (CSF) management devices, which are essential for treating conditions that affect the flow of cerebrospinal fluid, also play a significant role in the market. These devices are crucial for patients suffering from conditions such as hydrocephalus, where the abnormal accumulation of CSF can lead to increased intracranial pressure. The increasing incidence of such neurological disorders is driving continued innovation and adoption of CSF management solutions, ensuring better long-term outcomes for patients.

Neurology Devices Market End User Insights

The End User segment of the US Pediatric Neurology Devices Market is extensively categorized into hospitals and clinics, as well as specialty centers, reflecting the diverse applications of neurology devices in healthcare. Hospitals and clinics play a pivotal role in this market due to their capability to provide comprehensive patient care and access to advanced technologies which enhances the diagnosis and treatment of neurological disorders. Specialty centers are increasingly significant as well, offering focused expertise and advanced therapies specifically targeting neurological conditions.

The rising prevalence of neurological diseases necessitates specialized services, leading to an increased demand for innovative devices. Trends such as technological advancements and the integration of telemedicine within these facilities are bolstering market growth. Additionally, the shift towards minimally invasive procedures and outpatient care is indicative of a fundamental transformation in the treatment paradigms, fostering greater efficiency and patient satisfaction. As neurology continues to evolve, these end users emerge as essential contributors to the US Pediatric Neurology Devices Market, adapting to meet the complexities of neurological care in an ever-growing landscape.

Get more detailed insights about US Global Pediatric Neurology Devices Market
Request Free Sample

Key Players and Competitive Insights

The US Pediatric Neurology Devices Market is characterized by a rapidly evolving landscape marked by advancements in technology, a focus on patient-centric solutions, and the increasing prevalence of neurological disorders. Competition within this market is fierce, driven by the need for innovative treatments and diagnostic tools that can improve patient outcomes. Companies are fostering collaborations with healthcare providers and engaging in strategic partnerships to enhance their market positions. Key factors influencing this competition include the regulatory environment, reimbursement policies, and ongoing research and development initiatives aimed at addressing unmet medical needs.
Market stakeholders are also paying attention to shifting consumer preferences towards minimally invasive procedures and the integration of digital health technologies, which significantly impact product development and marketing strategies.
Integra LifeSciences has established a significant presence within the US Pediatric Neurology Devices Market, leveraging its extensive expertise in neurosurgery and neurocritical care. Known for its innovative neurocritical care solutions and surgical products, Integra LifeSciences has focused on developing high-quality devices that enhance surgical precision and safety. The company’s strength lies in its strong research and development pipeline, which enables it to introduce cutting-edge products that align with evolving clinical practices.
Furthermore, the robust distribution network and committed customer service have solidified its position in the market, allowing Integra LifeSciences to respond effectively to the needs of healthcare professionals and institutions across the United States.
TheraNest operates within the US Pediatric Neurology Devices Market, offering a range of products and services aimed at improving clinical efficiency in mental health and neurological therapy settings. The company focuses on providing robust solutions that enhance data management and treatment accessibility for practitioners. TheraNest's key offerings include software solutions designed to streamline patient management and documentation, reflecting its commitment to supporting healthcare providers in delivering efficient care. The company has strengthened its market presence through strategic partnerships and acquisitions that allow it to expand its portfolio and enhance service delivery.
TheraNest’s emphasis on user-friendly technology and integration capabilities has positioned it well amidst its competitors, making it a noteworthy entity in the realm of neurological devices tailored for the US market.

Key Companies in the US Global Pediatric Neurology Devices Market include

Industry Developments

The US Pediatric Neurology Devices Market has witnessed significant developments in recent months, with companies like Medtronic and Boston Scientific making strides in innovative treatments for neurological disorders. Integra LifeSciences announced the expansion of its neurosurgical product line to enhance patient outcomes in July 2023. Concurrently, Biogen's strategic initiatives have focused on the development of therapies for neurodegenerative diseases, showcasing their commitment to Research and Development. Additionally, in August 2023, Abbott Laboratories received FDA approval for a new neurostimulation device aimed at treating chronic pain.

The market has experienced increased investments, particularly in NeuroSigma, which recently launched a groundbreaking device for managing epilepsy. In terms of mergers and acquisitions, there were no significant public mergers or acquisitions reported for these companies in the recent timeframe. Over the past two to three years, the market has shown continuous growth, driven by technological advancements and escalating incidences of neurological disorders, thereby raising the valuation of leading companies such as Stryker and Johnson and Johnson. This growth underscores the importance of innovation and collaboration in the evolving landscape of neurological healthcare in the United States.

Future Outlook

US Global Pediatric Neurology Devices Market Future Outlook

Market Segmentation

Neurology Devices Market End User Outlook

  • hospitals & clinics
  • specialty center

Neurology Devices Market Product Type Outlook

  • neurostimulation
  • interventional neurology
  • csf management
  • neurosurgery devices

Report Scope

Report Attribute/Metric Source: Details
MARKET SIZE 2018 3.57(USD Billion)
MARKET SIZE 2024 4.0(USD Billion)
MARKET SIZE 2035 9.0(USD Billion)
COMPOUND ANNUAL GROWTH RATE (CAGR) 7.651% (2025 - 2035)
REPORT COVERAGE Revenue Forecast, Competitive Landscape, Growth Factors, and Trends
BASE YEAR 2024
MARKET FORECAST PERIOD 2025 - 2035
HISTORICAL DATA 2019 - 2024
MARKET FORECAST UNITS USD Billion
KEY COMPANIES PROFILED Integra LifeSciences, TheraNest, Zyga Technology, Medtronic, Boston Scientific, Abbott Laboratories, Stryker, Johnson and Johnson, Cochlear, NeuroSigma, Biogen, Blackrock Neurotech, NeuroPace, Neurovascular, Nervilab
SEGMENTS COVERED Product Type, End User
KEY MARKET OPPORTUNITIES Telemedicine integration for patient care, Advanced neuroimaging technologies development, Wearable brain monitoring devices, Robotics in neurosurgery applications, Digital therapeutics for neurological disorders
KEY MARKET DYNAMICS Technological advancements, Aging population, Increasing prevalence of neurological disorders, Growing demand for minimally invasive procedures, Rising healthcare expenditure
COUNTRIES COVERED US
Leave a Comment
Download Free Sample

Kindly complete the form below to receive a free sample of this Report

No regional reports available for this market.

No country-specific reports available for this market.

Customer Stories
Case Study
Aerospace & Defense
Future of Dismounted Soldier Systems Market Trends & Adoption Roadmap 2019–2035

Compare Licence

×
Features License Type
Single User Multiuser License Enterprise User
Price $4,950 $5,950 $7,250
Maximum User Access Limit 1 User Upto 10 Users Unrestricted Access Throughout the Organization
Free Customization ✓ ✓ ✓
Direct Access to Analyst ✓ ✓ ✓
Deliverable Format ✓ ✓ ✓
Platform Access ✗ ✗ ✓
Discount on Next Purchase 10% 15% 15%
Printable Versions ✗ ✗ ✓